Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs Vistra Corp (VST) Price & Performance

Novartis AGTrade
Vistra CorpTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Vistra Corp — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Vistra Corp trades at $162.33 (market cap $53.27B). The key difference: Novartis AG is far larger — about 5.4× Vistra Corp's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.

NVSVST
Market Cap
$290.25B$53.27B
Sector
HealthTechnology
52-Week High
$168.62$217.92
52-Week Low
$113.50$134.71
Enterprise Value
$330.27B$75.03B
Dividend Yield
3.17%0.58%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About Vistra Corp

Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.

Read more on VST